Determination of colistin-related nephrotoxicity and risk factors in intensive care unit

OBJECTIVE: Colistin is a cationic polypeptide antibiotic with a cyclic structure that belongs to the polymyxin group. It was banned from clinical use because of its significant renal side effects, such as nephrotoxicity. However, the administration of colistin has recently been initiated again in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Inci, Ayse, Toker, Melike Korkmaz, Bicer, Ilhan Guney, Derbent, Abdurrrahim, Salihoglu, Ziya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191557/
https://www.ncbi.nlm.nih.gov/pubmed/30374477
http://dx.doi.org/10.14744/nci.2017.42243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191557/
https://www.ncbi.nlm.nih.gov/pubmed/30374477
http://dx.doi.org/10.14744/nci.2017.42243

Ejemplares similares